ReviewJournal of translational medicine2026
Neutrophil extracellular traps in colorectal cancer: context-dependent roles from inflammatory carcinogenesis to liver metastasis and therapeutic targeting.
Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Colorectal cancer (CRC) develops and metastasizes within a microenvironment shaped by chronic inflammation, microbial exposure, stromal remodeling, and treatment pressure. Among the innate immune processes implicated in this setting, neutrophil extracellular traps (NETs) have attracted increasing attention. Initially described as antimicrobial structures, NETs have been implicated in several aspects of CRC biology, including inflammatory carcinogenesis, epithelial plasticity at the primary tumor site, gut-liver crosstalk, metastatic niche formation, and immune regulation. Experimental and translational studies suggest that they may influence tumor cell migration, extracellular matrix remodeling, hepatic colonization, and T-cell dysfunction, while also interacting with microbial and stromal signals in the liver. The available literature, however, does not support a uniformly deleterious role. Their biologic effect appears to vary with disease phase, anatomical site, neutrophil state, microbial context, and treatment exposure. In some settings, therapy-induced or early trap-associated responses may accompany tumor control rather than progression. In this review, we summarize current evidence on NETs in sporadic CRC, colitis-associated cancer (CAC), and colorectal cancer liver metastasis (CRLM), with particular attention to the gut-liver axis, immune microenvironment, biomarker development, and therapeutic intervention. We also discuss the major limitations of the field, including inconsistent detection strategies, overreliance on static or reductionist models, and limited spatially resolved human data. Overall, NETs may be better viewed as context-dependent effectors generated by distinct neutrophil states across different phases of disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.